Nutrition & Down Syndrome: Clinical Rationale & Results |
Author article list |
Robert J. Thiel, Ph.D., N.M.D. American Naturopathic Medical Association Monitor, Vol. 7, No. 1 |
Reprinted with the permission of the author |
There is no standard medical treatment for Down syndrome (trisomy 21). However nutritional therapy has been used to a limited degree for this population since Turkel pioneered it in 1940. In the 1980s, Warner modified Turkel's approach and continues to innovate. Others, such as Lawrence, Leichtman, and Thiel, have built on the foundation laid by Turkel and Warner. Although the use of nutrition is not considered as standard therapy by most in the medical community, this may be because practitioners have not sufficiently reviewed the literature which supports nutritional approaches as well as the fact that results are sometimes inconsistent. This paper points out some of the nutrients which may be different in the Down syndrome population such as vitamins A, B1, B6, B8, B12, C, D, and E; minerals such as calcium, copper, iron, magnesium, manganese, selenium, and zinc; and amino acids and other substances such as carnitine, carnosine, choline, cysteine, dimethylglycine, inositol, omega 6 fatty acids, phenylalanine, serine, superoxide-dismutase, and tryptophan. In addition, it reports that height and various aspects of facial appearance seem to improve for children with Down syndrome who try nutritional therapy. This paper also provides some rationale for why food nutrients are preferred for this population.
Gender | N | Attribute | Initial Mean | Final Mean |
---|---|---|---|---|
as Percentile on Down's Grid | ||||
Female | 36 | Height | 63.1% | 73.6% |
Male | 48 | Height | 63.6% | 77.8% |
Total | 84 | Height | 63.4% | 76.0% |
Gender | N | Attribute | Initial Mean | Final Mean |
---|---|---|---|---|
as Percentile on Down's Grid | ||||
Female | 40 | Weight | 60.9% | 59.3% |
Male | 50 | Weight | 45.2% | 53.7% |
Total | 90 | Weight | 52.2% | 56.2% |
Gender | N | Attibute | Initial Mean | Final Mean | Percent Improvement |
---|---|---|---|---|---|
on 10 Point Scale | |||||
Female | 39 | Facial Swelling | 5.9 | 4.2 | 28.8% |
Male | 46 | Facial Swelling | 6.6 | 2.8 | 57.6% |
Total | 85 | Facial Swelling | 6.3 | 3.4 | 46.0% |
Gender | N | Attibute | Initial Mean | Final Mean | Percent Improvement |
---|---|---|---|---|---|
on 10 Point Scale | |||||
Female | 37 | Nose Bridge | 7.8 | 5.1 | 34.6% |
Male | 45 | Nose Bridge | 7.5 | 5.2 | 30.7% |
Total | 82 | Nose Bridge | 7.6 | 5.1 | 32.9% |
Gender | N | Attibute | Initial Mean | Final Mean | Percent Improvement |
---|---|---|---|---|---|
on 10 Point Scale | |||||
Female | 38 | Epicanthal Fold | 5.4 | 3.8 | 29.6% |
Male | 43 | Epicanthal Fold | 6.1 | 4.0 | 34.4% |
Total | 81 | Epicanthal Fold | 5.8 | 3.9 | 32.8% |